Literature DB >> 701485

Inhibition of erythrocyte sickling in vitro by pyridoxal.

J A Kark, M P Kale, P G Tarassoff, M Woods, L S Lessin.   

Abstract

To test the antisickling activity of pyridoxal, we compared the oxygen affinity and the percent sickling at low PO2 of untreated erythrocytes with values for cells from the same blood sample incubated with pyridoxal, glyceraldehyde, or pyridoxine. Pyridoxal increased oxygen affinity much more than glyceraldehyde. 20 mM pyridoxal and glyceraldehyde had equivalent antisickling activity. At PO2 levels above 20 mm Hg, both agents reduced sickling to less than 2%. In samples examined by electron microscopy, pyridoxal reduced the percent sickled cells and the percent cells that contain hemoglobin S fibers by the same amount (from 74 to 3%). Pyridoxine had no effect on oxygen affinity or sockling. Pyridoxal reacts with intracellular hemoglobin to increase oxygen affinity, which inhibits hemoglobin S polymerization and sickling.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 701485      PMCID: PMC371842          DOI: 10.1172/JCI109202

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

Review 1.  Ultrastructural features of erythrocyte and hemoglobin sickling.

Authors:  J G White
Journal:  Arch Intern Med       Date:  1974-04

2.  Chemical modifications that inhibit gelation of sickle hemoglobin.

Authors:  R Benesch; R E Benesch; S Yung
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

3.  The sickle-unsickle cycle: a cause of cell fragmentation leading to permanently deformed cells.

Authors:  F Padilla; P A Bromberg; W N Jensen
Journal:  Blood       Date:  1973-05       Impact factor: 22.113

4.  Structure of human deoxyhemoglobin specifically modified with pyridoxal compounds.

Authors:  A Arnone; R E Benesch; R Benesch
Journal:  J Mol Biol       Date:  1977-10-05       Impact factor: 5.469

5.  Schiff base adducts of hemoglobin. Modifications that inhibit erythrocyte sickling.

Authors:  R H Zaugg; J A Walder; I M Klotz
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

6.  Pyridoxal compounds as specific reagents for the alpha and beta N-termini of hemoglobin.

Authors:  R E Benesch; S Yung; T Suzuki; C Bauer; R Benesch
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

7.  Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.

Authors:  A M Nigen; J M Manning
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

8.  5'-deoxypyridoxal as a potential anti-sickling agent.

Authors:  R Benesch; R E Benesch; R Edalji; T Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.

Authors:  A M Nigen; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  3 in total

Review 1.  Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control.

Authors:  J R Miranda-Massari; M J Gonzalez; F J Jimenez; M Z Allende-Vigo; J Duconge
Journal:  Curr Clin Pharmacol       Date:  2011-11

2.  Pyridoxal phosphate as an antisickling agent in vitro.

Authors:  J A Kark; P G Tarassoff; R Bongiovanni
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

3.  Sodium metabisulfite-induced polymerization of sickle cell hemoglobin incubated in the extracts of three medicinal plants (Anacardium occidentale, Psidium guajava, and Terminalia catappa).

Authors:  Paul Chidoka Chikezie
Journal:  Pharmacogn Mag       Date:  2011-04       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.